This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Immunomedics Inc (IMMU)

NASDAQ: Health Care

Company Balance Sheet
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Assets
Cash and Equivalents 6.96M 41.33M 32.84M 27.10M
Receivables 977.72K 1.25M 1.05M 1.71M
Inventories 778.99K 1.03M 415.88K 289.60K
Other Current Assets 180.68K 1.18M 593.90K 644.70K
Total Current Assets 44.74M 45.22M 35.48M 30.26M
Property, Plant & Equipment, Gross 29.21M 28.83M 28.24M 27.67M
Accumulated Depreciation & Depletion 27.31M 26.74M 25.71M 24.21M
Property, Plant & Equipment, Net 1.90M 2.09M 2.53M 3.46M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 206.11K 624.83K 628.29K 611.00K
Total Non-Current Assets 2.10M 2.71M 3.16M 4.07M
Liabilities & Shareholder Equity
Total Assets 46.84M 47.93M 38.64M 34.32M
Accounts Payable 2.37M 980.00K 512.00K 5.55M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 6.48M 9.95M 5.59M 5.55M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.50M 1.40M 1.30M 1.13M
Minority Interest -105.35K -104.76K -113.57K -173.99K
Total Non-Current Liabilities 1.01M 1.02M 1.01M 960.51K
Total Liabilities 7.49M 10.96M 6.61M 6.51M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 39.35M 36.97M 32.03M 27.82M
Common Par 931.13K 828.41K 755.97K 754.63K
Additional Paid In Capital 300.08M 265.69M 248.74M 245.02M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -261.47M -229.25M -217.09M -217.90M
Treasury Stock -458.37K -458.37K -458.37K -458.37K
Other Equity Adjustments 261.84K 161.83K 80.16K 394.67K
Total Capitalization 39.35M 36.97M 32.03M 27.82M
Total Equity 39.35M 36.97M 32.03M 27.82M
Total Liabilities & Stock Equity 46.84M 47.93M 38.64M 34.32M
Total Common Shares Outstanding 93.08M 82.81M 75.60M 75.46M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 34.72K 34.72K 34.72K 34.72K
Basic Weighted Shares Outstanding 84.63M 78.04M 75.48M 75.31M
Diluted Weighted Shares Outstanding 84.63M 78.04M 76.17M 75.31M
Number of Employees 120 119 124 121
Number of Part-Time Employees 0 0 0 0
IMMU News

IMMU Immunomedics Inc

Analysts Ratings for IMMU

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 2 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET IMMU ANALYST REPORT

Brokerage Partners

IMMU Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs